Clinical Trials Logo

Post-Traumatic Stress Disorder clinical trials

View clinical trials related to Post-Traumatic Stress Disorder.

Filter by:

NCT ID: NCT03196999 Completed - Clinical trials for Post Traumatic Stress Disorder

Remotely Resolving Psychological Stress (Remote RePS)

Start date: November 30, 2017
Phase: N/A
Study type: Interventional

The investigators have developed a mobile app called Resolving Psychological Stress (REPS) for people with posttraumatic stress disorder (PTSD). The app will administer threat-related attention bias modification to individuals who score high on a PTSD checklist. This study will be administered remotely to individuals in the United States. The aims of the study are to explore feasibility, acceptability and usability of the app in an entirely remote study, as well as to explore the efficacy of the app at reducing attention bias and PTSD symptom severity.

NCT ID: NCT03194386 Completed - Clinical trials for Post-Traumatic Stress Disorder

Eye-Movement Desensitization and Reprocessing in the ED and Post-Traumatic Syndrome

EMDR-ED
Start date: October 2016
Phase: N/A
Study type: Interventional

Millions people, all over the world, are admitted in the Emergency Department after a trauma or simply to receive medical cares. In France, it represents 10 million patients. Probably because of stress associated with the event, 20% will suffer a combination of non-specifics symptoms which persist for many months and with daily life quality impairment. The investigators hypothesize that an early intervention, such as Eye-Movement, Desensitization and Reprocessing (EMDR) could be performed in the ED and could prevent the occurrence of these symptoms

NCT ID: NCT03194113 Completed - Clinical trials for Post Traumatic Stress Disorder

Improving PTSD Treatments for Adults With Childhood Trauma

IMPACT
Start date: December 1, 2016
Phase: N/A
Study type: Interventional

The aim of this project is to investigate the effectiveness of phase-based trauma-focused therapy (PBT) and intensive trauma-focused therapy (I-TFT) for adult patients with PTSD related to childhood abuse. We will carry out a RCT, randomizing 150 patients to receive either standard TFT, PBT or i-TFT. The effects will be assessed at two endpoints of treatment (4, 8 and 16 weeks) and after a 6 and 12 months follow-up in an intention-to-treat analysis.

NCT ID: NCT03191929 Completed - Depression Clinical Trials

Depression Screening in Primary Care: Using HIT for Patients With Limited English

Start date: August 2011
Phase: N/A
Study type: Interventional

This study assessed the potential of Health Information Technology (HIT) to improve the screening, diagnosis, and treatment of depression and post-traumatic stress among LEP Southeast Asians. Should this intervention be found to be effective, the principles of the HIT technology could be easily adapted for screening in other languages to increase the recognition and treatment of depression and PTSD in primary care settings.

NCT ID: NCT03191760 Completed - Clinical trials for Post-Traumatic Stress Disorder

Open Trial of Behavioral Activation and Social Engagement (BASE) for Posttraumatic Stress Disorder (PTSD)

PTSD
Start date: June 8, 2017
Phase: N/A
Study type: Interventional

The purpose of the study is to see if "Behavioral Activation and Social Engagement for PTSD" (BASE for PTSD), an individual therapy for PTSD, will help Veterans with PTSD 1) through improved understanding of how PTSD affects them, 2) by reducing ways in which they avoid meaningful activity due to PTSD, 3) by enabling them to do more of the things they really care about, and 4) by improving, strengthening, and building up their social supports.

NCT ID: NCT03166501 Completed - Depression Clinical Trials

NMDA Receptor Modulation for Hyperarousal in PTSD

Start date: September 1, 2018
Phase: Phase 1
Study type: Interventional

This Phase 1b study examines the safety and efficacy of parenterally-administered lanicemine in a parallel-arm, randomized, double-blind, placebo-controlled trial in adult patients (N=24) with significant PTSD symptoms and elevated anxiety potentiated startle (APS). Investigator hypothesize that lanicemine (100 mg) displays a normalization of APS following three infusions over 5 non-consecutive days. If target engagement is demonstrated and the drug is safe and tolerable in this patient population, investigator will proceed to a larger POC study.

NCT ID: NCT03154151 Completed - Clinical trials for Post-Traumatic Stress Disorder

Online Therapy for Posttraumatic Stress Symptoms in WTC Responders and Survivors

Start date: August 21, 2017
Phase: N/A
Study type: Interventional

If you worked or volunteered as a WTC rescue, recovery or clean-up worker after the 9/11 attacks, or are a survivor of the WTC 9/11 attacks, and you are still experiencing Posttraumatic Stress Disorder (PTSD) symptoms related to your WTC experience, you might be eligible to participate in this clinical trial of therapist-assisted, Internet-based (online) writing therapy for WTC responders and survivors with persistent PTSD symptoms. This study is for WTC responders and survivors who are not currently receiving psychotherapy/counseling. In this study, the researchers aim to find out if Internet-based therapy can help WTC responders and survivors who are still experiencing PTSD symptoms.

NCT ID: NCT03114891 Completed - Clinical trials for Major Depressive Disorder

Accelerated TMS to a Novel Brain Target in MDD and PTSD

Start date: April 20, 2017
Phase: N/A
Study type: Interventional

This is a Clinical Trial designed to evaluate novel transcranial magnetic stimulation (TMS) methods for treating depression/PTSD. TMS is an FDA-approved procedure for treatment-resistant depression. The use of the stimulation in this current study is considered experimental. The purpose of this research study is to compare the effects of TMS at two different brain regions. This information will help the investigators to determine which treatment strategies provide the greatest clinical benefit to patients. Results of the study will provide brain and behavior measures for future work, which may be critical to developing effective disease markers and novel treatments for psychiatric conditions.

NCT ID: NCT03113175 Completed - Clinical trials for Post Traumatic Stress Disorder

Collabri Flex - Effect of Collaborative Care for People With Anxiety Disorders in General Practice

Start date: January 15, 2018
Phase: N/A
Study type: Interventional

The aim of the study Collabri Flex is to: - Develop a Danish model for collaborative care for patients with anxiety in general practice, based on past experience gained in the Collabri Project. - Examine the impact of this model compared with liaison-consultation for people with anxiety in a randomized controlled design from selected endpoints.

NCT ID: NCT03103165 Completed - Depression Clinical Trials

SimCoach Evaluation: : A Virtual Human Intervention to Encourage Servicemember Help-seeking for PTSD and Depression

Start date: October 2012
Phase: N/A
Study type: Interventional

SimCoach, a computer program featuring a virtual human that speaks and gestures in a videogame-like interface, is designed to encourage servicemembers to seek help to improve their psychological health.